Research programme: cannabinoid receptor agonists - Organix
Alternative Names: O-1057Latest Information Update: 27 Jun 2006
At a glance
- Originator Organix
- Developer Virginia Commonwealth University
- Class Non-opioid analgesics
- Mechanism of Action Cannabinoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 27 Jun 2006 No development reported - Preclinical for Pain in USA (unspecified route)
- 14 Mar 2002 Preclinical trials in Pain in USA (unspecified route)